 | • レポートコード：QYR2104Z3970 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、筋弛緩薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（メトカルバモール、シクロベンザプリン、チザニジン、バクロフェン、その他）、用途別市場規模（オンライン薬局、小売薬局、病院薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・筋弛緩薬の市場動向 ・企業の競争状況、市場シェア ・筋弛緩薬の種類別市場規模（メトカルバモール、シクロベンザプリン、チザニジン、バクロフェン、その他） ・筋弛緩薬の用途別市場規模（オンライン薬局、小売薬局、病院薬局） ・筋弛緩薬の北米市場規模2016-2027（アメリカ、カナダ） ・筋弛緩薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・筋弛緩薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・筋弛緩薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・筋弛緩薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Allergan、Ipsen Group、Teva Pharmaceuticals、Novartis、Johnson & Johnson、Takeda Pharmaceutical、Sun Pharmaceutical、Merz Pharma、Mylan、Fresenius Kabi、Endo International、Par Sterile Products、Acorda Therapeutics、SteriMax Inc、Emcure Pharmaceuticals、Upsher-Smith Laboratories、Orient Pharma、Daewoong Pharmaceutical） ・結論 |
Market Analysis and Insights: Global Muscle Relaxers Market
The global Muscle Relaxers market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Muscle Relaxers market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Muscle Relaxers market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Muscle Relaxers market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Muscle Relaxers market.
Global Muscle Relaxers Scope and Market Size
Muscle Relaxers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Muscle Relaxers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Methocarbamol
Cyclobenzaprine
Tizanidine
Baclofen
Others
Segment by Application
Online Pharmacies
Retail Pharmacies
Hospital Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Allergan
Ipsen Group
Teva Pharmaceuticals
Novartis
Johnson & Johnson
Takeda Pharmaceutical
Sun Pharmaceutical
Merz Pharma
Mylan
Fresenius Kabi
Endo International
Par Sterile Products
Acorda Therapeutics
SteriMax Inc
Emcure Pharmaceuticals
Upsher-Smith Laboratories
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Muscle Relaxers Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Methocarbamol
1.2.3 Cyclobenzaprine
1.2.4 Tizanidine
1.2.5 Baclofen
1.2.6 Others
1.3 Market by Application
1.3.1 Global Muscle Relaxers Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Online Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Hospital Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Muscle Relaxers Market Perspective (2016-2027)
2.2 Muscle Relaxers Growth Trends by Regions
2.2.1 Muscle Relaxers Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Muscle Relaxers Historic Market Share by Regions (2016-2021)
2.2.3 Muscle Relaxers Forecasted Market Size by Regions (2022-2027)
2.3 Muscle Relaxers Industry Dynamic
2.3.1 Muscle Relaxers Market Trends
2.3.2 Muscle Relaxers Market Drivers
2.3.3 Muscle Relaxers Market Challenges
2.3.4 Muscle Relaxers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Muscle Relaxers Players by Revenue
3.1.1 Global Top Muscle Relaxers Players by Revenue (2016-2021)
3.1.2 Global Muscle Relaxers Revenue Market Share by Players (2016-2021)
3.2 Global Muscle Relaxers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Muscle Relaxers Revenue
3.4 Global Muscle Relaxers Market Concentration Ratio
3.4.1 Global Muscle Relaxers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Muscle Relaxers Revenue in 2020
3.5 Muscle Relaxers Key Players Head office and Area Served
3.6 Key Players Muscle Relaxers Product Solution and Service
3.7 Date of Enter into Muscle Relaxers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Muscle Relaxers Breakdown Data by Type
4.1 Global Muscle Relaxers Historic Market Size by Type (2016-2021)
4.2 Global Muscle Relaxers Forecasted Market Size by Type (2022-2027)
5 Muscle Relaxers Breakdown Data by Application
5.1 Global Muscle Relaxers Historic Market Size by Application (2016-2021)
5.2 Global Muscle Relaxers Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Muscle Relaxers Market Size (2016-2027)
6.2 North America Muscle Relaxers Market Size by Type
6.2.1 North America Muscle Relaxers Market Size by Type (2016-2021)
6.2.2 North America Muscle Relaxers Market Size by Type (2022-2027)
6.2.3 North America Muscle Relaxers Market Size by Type (2016-2027)
6.3 North America Muscle Relaxers Market Size by Application
6.3.1 North America Muscle Relaxers Market Size by Application (2016-2021)
6.3.2 North America Muscle Relaxers Market Size by Application (2022-2027)
6.3.3 North America Muscle Relaxers Market Size by Application (2016-2027)
6.4 North America Muscle Relaxers Market Size by Country
6.4.1 North America Muscle Relaxers Market Size by Country (2016-2021)
6.4.2 North America Muscle Relaxers Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Muscle Relaxers Market Size (2016-2027)
7.2 Europe Muscle Relaxers Market Size by Type
7.2.1 Europe Muscle Relaxers Market Size by Type (2016-2021)
7.2.2 Europe Muscle Relaxers Market Size by Type (2022-2027)
7.2.3 Europe Muscle Relaxers Market Size by Type (2016-2027)
7.3 Europe Muscle Relaxers Market Size by Application
7.3.1 Europe Muscle Relaxers Market Size by Application (2016-2021)
7.3.2 Europe Muscle Relaxers Market Size by Application (2022-2027)
7.3.3 Europe Muscle Relaxers Market Size by Application (2016-2027)
7.4 Europe Muscle Relaxers Market Size by Country
7.4.1 Europe Muscle Relaxers Market Size by Country (2016-2021)
7.4.2 Europe Muscle Relaxers Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Muscle Relaxers Market Size (2016-2027)
8.2 Asia-Pacific Muscle Relaxers Market Size by Type
8.2.1 Asia-Pacific Muscle Relaxers Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Muscle Relaxers Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Muscle Relaxers Market Size by Type (2016-2027)
8.3 Asia-Pacific Muscle Relaxers Market Size by Application
8.3.1 Asia-Pacific Muscle Relaxers Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Muscle Relaxers Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Muscle Relaxers Market Size by Application (2016-2027)
8.4 Asia-Pacific Muscle Relaxers Market Size by Region
8.4.1 Asia-Pacific Muscle Relaxers Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Muscle Relaxers Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Muscle Relaxers Market Size (2016-2027)
9.2 Latin America Muscle Relaxers Market Size by Type
9.2.1 Latin America Muscle Relaxers Market Size by Type (2016-2021)
9.2.2 Latin America Muscle Relaxers Market Size by Type (2022-2027)
9.2.3 Latin America Muscle Relaxers Market Size by Type (2016-2027)
9.3 Latin America Muscle Relaxers Market Size by Application
9.3.1 Latin America Muscle Relaxers Market Size by Application (2016-2021)
9.3.2 Latin America Muscle Relaxers Market Size by Application (2022-2027)
9.3.3 Latin America Muscle Relaxers Market Size by Application (2016-2027)
9.4 Latin America Muscle Relaxers Market Size by Country
9.4.1 Latin America Muscle Relaxers Market Size by Country (2016-2021)
9.4.2 Latin America Muscle Relaxers Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Muscle Relaxers Market Size (2016-2027)
10.2 Middle East & Africa Muscle Relaxers Market Size by Type
10.2.1 Middle East & Africa Muscle Relaxers Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Muscle Relaxers Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Muscle Relaxers Market Size by Type (2016-2027)
10.3 Middle East & Africa Muscle Relaxers Market Size by Application
10.3.1 Middle East & Africa Muscle Relaxers Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Muscle Relaxers Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Muscle Relaxers Market Size by Application (2016-2027)
10.4 Middle East & Africa Muscle Relaxers Market Size by Country
10.4.1 Middle East & Africa Muscle Relaxers Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Muscle Relaxers Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Muscle Relaxers Introduction
11.1.4 Pfizer Revenue in Muscle Relaxers Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Muscle Relaxers Introduction
11.2.4 Allergan Revenue in Muscle Relaxers Business (2016-2021)
11.2.5 Allergan Recent Development
11.3 Ipsen Group
11.3.1 Ipsen Group Company Details
11.3.2 Ipsen Group Business Overview
11.3.3 Ipsen Group Muscle Relaxers Introduction
11.3.4 Ipsen Group Revenue in Muscle Relaxers Business (2016-2021)
11.3.5 Ipsen Group Recent Development
11.4 Teva Pharmaceuticals
11.4.1 Teva Pharmaceuticals Company Details
11.4.2 Teva Pharmaceuticals Business Overview
11.4.3 Teva Pharmaceuticals Muscle Relaxers Introduction
11.4.4 Teva Pharmaceuticals Revenue in Muscle Relaxers Business (2016-2021)
11.4.5 Teva Pharmaceuticals Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Muscle Relaxers Introduction
11.5.4 Novartis Revenue in Muscle Relaxers Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Muscle Relaxers Introduction
11.6.4 Johnson & Johnson Revenue in Muscle Relaxers Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Details
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Muscle Relaxers Introduction
11.7.4 Takeda Pharmaceutical Revenue in Muscle Relaxers Business (2016-2021)
11.7.5 Takeda Pharmaceutical Recent Development
11.8 Sun Pharmaceutical
11.8.1 Sun Pharmaceutical Company Details
11.8.2 Sun Pharmaceutical Business Overview
11.8.3 Sun Pharmaceutical Muscle Relaxers Introduction
11.8.4 Sun Pharmaceutical Revenue in Muscle Relaxers Business (2016-2021)
11.8.5 Sun Pharmaceutical Recent Development
11.9 Merz Pharma
11.9.1 Merz Pharma Company Details
11.9.2 Merz Pharma Business Overview
11.9.3 Merz Pharma Muscle Relaxers Introduction
11.9.4 Merz Pharma Revenue in Muscle Relaxers Business (2016-2021)
11.9.5 Merz Pharma Recent Development
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Mylan Business Overview
11.10.3 Mylan Muscle Relaxers Introduction
11.10.4 Mylan Revenue in Muscle Relaxers Business (2016-2021)
11.10.5 Mylan Recent Development
11.11 Fresenius Kabi
11.11.1 Fresenius Kabi Company Details
11.11.2 Fresenius Kabi Business Overview
11.11.3 Fresenius Kabi Muscle Relaxers Introduction
11.11.4 Fresenius Kabi Revenue in Muscle Relaxers Business (2016-2021)
11.11.5 Fresenius Kabi Recent Development
11.12 Endo International
11.12.1 Endo International Company Details
11.12.2 Endo International Business Overview
11.12.3 Endo International Muscle Relaxers Introduction
11.12.4 Endo International Revenue in Muscle Relaxers Business (2016-2021)
11.12.5 Endo International Recent Development
11.13 Par Sterile Products
11.13.1 Par Sterile Products Company Details
11.13.2 Par Sterile Products Business Overview
11.13.3 Par Sterile Products Muscle Relaxers Introduction
11.13.4 Par Sterile Products Revenue in Muscle Relaxers Business (2016-2021)
11.13.5 Par Sterile Products Recent Development
11.14 Acorda Therapeutics
11.14.1 Acorda Therapeutics Company Details
11.14.2 Acorda Therapeutics Business Overview
11.14.3 Acorda Therapeutics Muscle Relaxers Introduction
11.14.4 Acorda Therapeutics Revenue in Muscle Relaxers Business (2016-2021)
11.14.5 Acorda Therapeutics Recent Development
11.15 SteriMax Inc
11.15.1 SteriMax Inc Company Details
11.15.2 SteriMax Inc Business Overview
11.15.3 SteriMax Inc Muscle Relaxers Introduction
11.15.4 SteriMax Inc Revenue in Muscle Relaxers Business (2016-2021)
11.15.5 SteriMax Inc Recent Development
11.16 Emcure Pharmaceuticals
11.16.1 Emcure Pharmaceuticals Company Details
11.16.2 Emcure Pharmaceuticals Business Overview
11.16.3 Emcure Pharmaceuticals Muscle Relaxers Introduction
11.16.4 Emcure Pharmaceuticals Revenue in Muscle Relaxers Business (2016-2021)
11.16.5 Emcure Pharmaceuticals Recent Development
11.17 Upsher-Smith Laboratories
11.17.1 Upsher-Smith Laboratories Company Details
11.17.2 Upsher-Smith Laboratories Business Overview
11.17.3 Upsher-Smith Laboratories Muscle Relaxers Introduction
11.17.4 Upsher-Smith Laboratories Revenue in Muscle Relaxers Business (2016-2021)
11.17.5 Upsher-Smith Laboratories Recent Development
11.18 Orient Pharma
11.18.1 Orient Pharma Company Details
11.18.2 Orient Pharma Business Overview
11.18.3 Orient Pharma Muscle Relaxers Introduction
11.18.4 Orient Pharma Revenue in Muscle Relaxers Business (2016-2021)
11.18.5 Orient Pharma Recent Development
11.18 Daewoong Pharmaceutical
.1 Daewoong Pharmaceutical Company Details
.2 Daewoong Pharmaceutical Business Overview
.3 Daewoong Pharmaceutical Muscle Relaxers Introduction
.4 Daewoong Pharmaceutical Revenue in Muscle Relaxers Business (2016-2021)
.5 Daewoong Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Muscle Relaxers Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Methocarbamol
Table 3. Key Players of Cyclobenzaprine
Table 4. Key Players of Tizanidine
Table 5. Key Players of Baclofen
Table 6. Key Players of Others
Table 7. Global Muscle Relaxers Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Muscle Relaxers Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Muscle Relaxers Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Muscle Relaxers Market Share by Regions (2016-2021)
Table 11. Global Muscle Relaxers Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Muscle Relaxers Market Share by Regions (2022-2027)
Table 13. Muscle Relaxers Market Trends
Table 14. Muscle Relaxers Market Drivers
Table 15. Muscle Relaxers Market Challenges
Table 16. Muscle Relaxers Market Restraints
Table 17. Global Muscle Relaxers Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Muscle Relaxers Market Share by Players (2016-2021)
Table 19. Global Top Muscle Relaxers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Muscle Relaxers as of 2020)
Table 20. Ranking of Global Top Muscle Relaxers Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Muscle Relaxers Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Muscle Relaxers Product Solution and Service
Table 24. Date of Enter into Muscle Relaxers Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Muscle Relaxers Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Muscle Relaxers Revenue Market Share by Type (2016-2021)
Table 28. Global Muscle Relaxers Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Muscle Relaxers Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Muscle Relaxers Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Muscle Relaxers Revenue Market Share by Application (2016-2021)
Table 32. Global Muscle Relaxers Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Muscle Relaxers Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Muscle Relaxers Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Muscle Relaxers Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Muscle Relaxers Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Muscle Relaxers Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Muscle Relaxers Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Muscle Relaxers Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Muscle Relaxers Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Muscle Relaxers Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Muscle Relaxers Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Muscle Relaxers Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Muscle Relaxers Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Muscle Relaxers Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Muscle Relaxers Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Muscle Relaxers Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Muscle Relaxers Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Muscle Relaxers Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Muscle Relaxers Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Muscle Relaxers Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Muscle Relaxers Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Muscle Relaxers Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Muscle Relaxers Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Muscle Relaxers Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Muscle Relaxers Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Muscle Relaxers Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Muscle Relaxers Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Muscle Relaxers Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Muscle Relaxers Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Muscle Relaxers Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Muscle Relaxers Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Muscle Relaxers Market Size by Country (2022-2027) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Muscle Relaxers Product
Table 67. Pfizer Revenue in Muscle Relaxers Business (2016-2021) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. Allergan Company Details
Table 70. Allergan Business Overview
Table 71. Allergan Muscle Relaxers Product
Table 72. Allergan Revenue in Muscle Relaxers Business (2016-2021) & (US$ Million)
Table 73. Allergan Recent Development
Table 74. Ipsen Group Company Details
Table 75. Ipsen Group Business Overview
Table 76. Ipsen Group Muscle Relaxers Product
Table 77. Ipsen Group Revenue in Muscle Relaxers Business (2016-2021) & (US$ Million)
Table 78. Ipsen Group Recent Development
Table 79. Teva Pharmaceuticals Company Details
Table 80. Teva Pharmaceuticals Business Overview
Table 81. Teva Pharmaceuticals Muscle Relaxers Product
Table 82. Teva Pharmaceuticals Revenue in Muscle Relaxers Business (2016-2021) & (US$ Million)
Table 83. Teva Pharmaceuticals Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Muscle Relaxers Product
Table 87. Novartis Revenue in Muscle Relaxers Business (2016-2021) & (US$ Million)
Table 88. Novartis Recent Development
Table 89. Johnson & Johnson Company Details
Table 90. Johnson & Johnson Business Overview
Table 91. Johnson & Johnson Muscle Relaxers Product
Table 92. Johnson & Johnson Revenue in Muscle Relaxers Business (2016-2021) & (US$ Million)
Table 93. Johnson & Johnson Recent Development
Table 94. Takeda Pharmaceutical Company Details
Table 95. Takeda Pharmaceutical Business Overview
Table 96. Takeda Pharmaceutical Muscle Relaxers Product
Table 97. Takeda Pharmaceutical Revenue in Muscle Relaxers Business (2016-2021) & (US$ Million)
Table 98. Takeda Pharmaceutical Recent Development
Table 99. Sun Pharmaceutical Company Details
Table 100. Sun Pharmaceutical Business Overview
Table 101. Sun Pharmaceutical Revenue in Muscle Relaxers Business (2016-2021) & (US$ Million)
Table 102. Sun Pharmaceutical Recent Development
Table 103. Merz Pharma Company Details
Table 104. Merz Pharma Business Overview
Table 105. Merz Pharma Muscle Relaxers Product
Table 106. Merz Pharma Revenue in Muscle Relaxers Business (2016-2021) & (US$ Million)
Table 107. Merz Pharma Recent Development
Table 108. Mylan Company Details
Table 109. Mylan Business Overview
Table 110. Mylan Muscle Relaxers Product
Table 111. Mylan Revenue in Muscle Relaxers Business (2016-2021) & (US$ Million)
Table 112. Mylan Recent Development
Table 113. Fresenius Kabi Company Details
Table 114. Fresenius Kabi Business Overview
Table 115. Fresenius Kabi Muscle Relaxers Product
Table 116. Fresenius Kabi Revenue in Muscle Relaxers Business (2016-2021) & (US$ Million)
Table 117. Fresenius Kabi Recent Development
Table 118. Endo International Company Details
Table 119. Endo International Business Overview
Table 120. Endo International Muscle Relaxers Product
Table 121. Endo International Revenue in Muscle Relaxers Business (2016-2021) & (US$ Million)
Table 122. Endo International Recent Development
Table 123. Par Sterile Products Company Details
Table 124. Par Sterile Products Business Overview
Table 125. Par Sterile Products Muscle Relaxers Product
Table 126. Par Sterile Products Revenue in Muscle Relaxers Business (2016-2021) & (US$ Million)
Table 127. Par Sterile Products Recent Development
Table 128. Acorda Therapeutics Company Details
Table 129. Acorda Therapeutics Business Overview
Table 130. Acorda Therapeutics Muscle Relaxers Product
Table 131. Acorda Therapeutics Revenue in Muscle Relaxers Business (2016-2021) & (US$ Million)
Table 132. Acorda Therapeutics Recent Development
Table 133. SteriMax Inc Company Details
Table 134. SteriMax Inc Business Overview
Table 135. SteriMax Inc Muscle Relaxers Product
Table 136. SteriMax Inc Revenue in Muscle Relaxers Business (2016-2021) & (US$ Million)
Table 137. SteriMax Inc Recent Development
Table 138. Emcure Pharmaceuticals Company Details
Table 139. Emcure Pharmaceuticals Business Overview
Table 140. Emcure Pharmaceuticals Muscle Relaxers Product
Table 141. Emcure Pharmaceuticals Revenue in Muscle Relaxers Business (2016-2021) & (US$ Million)
Table 142. Emcure Pharmaceuticals Recent Development
Table 143. Upsher-Smith Laboratories Company Details
Table 144. Upsher-Smith Laboratories Business Overview
Table 145. Upsher-Smith Laboratories Muscle Relaxers Product
Table 146. Upsher-Smith Laboratories Revenue in Muscle Relaxers Business (2016-2021) & (US$ Million)
Table 147. Upsher-Smith Laboratories Recent Development
Table 148. Orient Pharma Company Details
Table 149. Orient Pharma Business Overview
Table 150. Orient Pharma Muscle Relaxers Product
Table 151. Orient Pharma Revenue in Muscle Relaxers Business (2016-2021) & (US$ Million)
Table 152. Orient Pharma Recent Development
Table 153. Daewoong Pharmaceutical Company Details
Table 154. Daewoong Pharmaceutical Business Overview
Table 155. Daewoong Pharmaceutical Muscle Relaxers Product
Table 156. Daewoong Pharmaceutical Revenue in Muscle Relaxers Business (2016-2021) & (US$ Million)
Table 157. Daewoong Pharmaceutical Recent Development
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Muscle Relaxers Market Share by Type: 2020 VS 2027
Figure 2. Methocarbamol Features
Figure 3. Cyclobenzaprine Features
Figure 4. Tizanidine Features
Figure 5. Baclofen Features
Figure 6. Others Features
Figure 7. Global Muscle Relaxers Market Share by Application: 2020 VS 2027
Figure 8. Online Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Muscle Relaxers Report Years Considered
Figure 12. Global Muscle Relaxers Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Muscle Relaxers Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Muscle Relaxers Market Share by Regions: 2020 VS 2027
Figure 15. Global Muscle Relaxers Market Share by Regions (2022-2027)
Figure 16. Global Muscle Relaxers Market Share by Players in 2020
Figure 17. Global Top Muscle Relaxers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Muscle Relaxers as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Muscle Relaxers Revenue in 2020
Figure 19. Global Muscle Relaxers Revenue Market Share by Type (2016-2021)
Figure 20. Global Muscle Relaxers Revenue Market Share by Type (2022-2027)
Figure 21. North America Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Muscle Relaxers Market Share by Type (2016-2027)
Figure 23. North America Muscle Relaxers Market Share by Application (2016-2027)
Figure 24. North America Muscle Relaxers Market Share by Country (2016-2027)
Figure 25. United States Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Muscle Relaxers Market Share by Type (2016-2027)
Figure 29. Europe Muscle Relaxers Market Share by Application (2016-2027)
Figure 30. Europe Muscle Relaxers Market Share by Country (2016-2027)
Figure 31. Germany Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Muscle Relaxers Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Muscle Relaxers Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Muscle Relaxers Market Share by Region (2016-2027)
Figure 41. China Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Muscle Relaxers Market Share by Type (2016-2027)
Figure 49. Latin America Muscle Relaxers Market Share by Application (2016-2027)
Figure 50. Latin America Muscle Relaxers Market Share by Country (2016-2027)
Figure 51. Mexico Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Muscle Relaxers Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Muscle Relaxers Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Muscle Relaxers Market Share by Country (2016-2027)
Figure 57. Turkey Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Muscle Relaxers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Pfizer Revenue Growth Rate in Muscle Relaxers Business (2016-2021)
Figure 61. Allergan Revenue Growth Rate in Muscle Relaxers Business (2016-2021)
Figure 62. Ipsen Group Revenue Growth Rate in Muscle Relaxers Business (2016-2021)
Figure 63. Teva Pharmaceuticals Revenue Growth Rate in Muscle Relaxers Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Muscle Relaxers Business (2016-2021)
Figure 65. Johnson & Johnson Revenue Growth Rate in Muscle Relaxers Business (2016-2021)
Figure 66. Takeda Pharmaceutical Revenue Growth Rate in Muscle Relaxers Business (2016-2021)
Figure 67. Sun Pharmaceutical Revenue Growth Rate in Muscle Relaxers Business (2016-2021)
Figure 68. Merz Pharma Revenue Growth Rate in Muscle Relaxers Business (2016-2021)
Figure 69. Mylan Revenue Growth Rate in Muscle Relaxers Business (2016-2021)
Figure 70. Fresenius Kabi Revenue Growth Rate in Muscle Relaxers Business (2016-2021)
Figure 71. Endo International Revenue Growth Rate in Muscle Relaxers Business (2016-2021)
Figure 72. Par Sterile Products Revenue Growth Rate in Muscle Relaxers Business (2016-2021)
Figure 73. Acorda Therapeutics Revenue Growth Rate in Muscle Relaxers Business (2016-2021)
Figure 74. SteriMax Inc Revenue Growth Rate in Muscle Relaxers Business (2016-2021)
Figure 75. Emcure Pharmaceuticals Revenue Growth Rate in Muscle Relaxers Business (2016-2021)
Figure 76. Upsher-Smith Laboratories Revenue Growth Rate in Muscle Relaxers Business (2016-2021)
Figure 77. Orient Pharma Revenue Growth Rate in Muscle Relaxers Business (2016-2021)
Figure 78. Daewoong Pharmaceutical Revenue Growth Rate in Muscle Relaxers Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
世界の局所疼痛管理治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Topical Pain Management Therapeutics Market The global Topical Pain Management Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and h…- 世界のOTC鎮痛薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global OTC Analgesics Market The global OTC Analgesics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…
- 世界のバクロフェン市場 2021：企業別、地域別、種類・用途別 The Baclofen market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent de…
- 世界のクッシング病治療市場規模・現状・予測（2021年-2027年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
- 世界の結節性痒疹治療市場規模・現状・予測（2021年-2027年） Prurigo nodularis (PN), also known as nodular prurigo, is a skin disease characterised by pruritic (itchy) nodules which usually appear on the arms or legs. Among products, antihistamines are foreseen to exhibit a higher CAGR in the global prurigo nodularis treatment market. Market Analysis and Insi…